×
0 0 0 0 0 0 0 0.0064879356568365
Stockreport

Molecular Partners agrees cancer immunotherapy deal with Amgen [Reuters (UK)]

Amgen, Inc (AMGN)  More Company Research Source: Reuters
Last amgen, inc earnings: 10/30 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.amgen.com
PDF Molecular Partners agrees cancer immunotherapy deal with Amgen | Reuters 2 Min Read ZURICH (Reuters) - Swiss biotechnology company Molecular Partners ( MOLN.S ) said it could earn more than $500 million (395 million pounds) in payments after striking a deal with U.S. drug giant Amgen ( AMGN.O ) to work together in cancer immunotherapy. The deal, which includes $50 million upfront, is a welcome liquidity infusion for Zurich-based Molecular, which said last year it could sell more shares or seek a partner for one of its pipeline assets to replenish its coffers by 2019. [ reut.rs/2Lo3Yjp ] In addition to the upfront money, Molecular Partners could get as much as $497 million in milestone payments from Amgen, as well as double-digit, tiered royalties up to the high teens. The companies will share clinical development costs for the first three indications, they said. The deal involves Molecular Partner’s experimental, pre-clinical molecule, called MP0310, designed to locally activate i [Read more]

IMPACT SNAPSHOT EVENT TIME: AMGN
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
POST NEWS RANGE
%
PRICE CHANGE

PRICE CHANGE PERCENTAGE


S&P 500 (SPX)

%

VOLUME RATIO
%

VOLUME (SHARES)
TICKS

AVG SHARES PER TRADE

Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Opt-in for
AMGN alerts

from News Quantified
Opt-in for
AMGN alerts

from News Quantified